BCRX
Price
$9.73
Change
-$0.20 (-2.01%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
2.04B
36 days until earnings call
PLUR
Price
$5.30
Change
+$0.88 (+19.91%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
34.79M
PULM
Price
$6.84
Change
-$0.21 (-2.98%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
25.75M
42 days until earnings call
Interact to see
Advertisement

BCRX or PLUR or PULM

Header iconBCRX vs PLUR vs PULM Comparison
Open Charts BCRX vs PLUR vs PULMBanner chart's image
BioCryst Pharmaceuticals
Price$9.73
Change-$0.20 (-2.01%)
Volume$101.03K
Capitalization2.04B
Pluri
Price$5.30
Change+$0.88 (+19.91%)
Volume$6.46K
Capitalization34.79M
Pulmatrix
Price$6.84
Change-$0.21 (-2.98%)
Volume$100
Capitalization25.75M
BCRX vs PLUR vs PULM Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (BCRX: $9.93PLUR: $4.42PULM: $7.05)
Brand notoriety: PLUR and PULM are not notable and BCRX is notable
The three companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 47%, PLUR: 70%, PULM: 46%
Market capitalization -- PLUR: $34.79M, PULM: $25.75M, BCRX: $2.04B
$BCRX is valued at $2.04B, while PLUR has a market capitalization of $34.79M, and PULM's market capitalization is $25.75M. The market cap for tickers in this @Biotechnology ranges from $312.97B to $0. The average market capitalization across the @Biotechnology industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 0 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s), and PULM’s FA Score reflects 0 green FA rating(s).

  • BCRX’s FA Score: 0 green, 5 red.
  • PLUR’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX and PULM are a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while PULM’s TA Score has 5 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 4 bearish.
  • PULM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BCRX and PULM are a good buy in the short-term.

Price Growth

BCRX (@Biotechnology) experienced а -0.40% price change this week, while PLUR (@Biotechnology) price change was +4.25% , and PULM (@Biotechnology) price fluctuated -13.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

PLUR is expected to report earnings on May 13, 2025.

PULM is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($2.04B) has a higher market cap than PLUR($34.8M) and PULM($25.7M). BCRX YTD gains are higher at: 32.048 vs. PLUR (3.392) and PULM (1.003). BCRX has higher annual earnings (EBITDA): 47.6M vs. PULM (-9.58M) and PLUR (-20.22M). BCRX has more cash in the bank: 295M vs. PLUR (26.3M) and PULM (7.71M). PULM has less debt than PLUR and BCRX: PULM (0) vs PLUR (31.2M) and BCRX (795M). BCRX has higher revenues than PULM and PLUR: BCRX (503M) vs PULM (1.92M) and PLUR (1.03M).
BCRXPLURPULM
Capitalization2.04B34.8M25.7M
EBITDA47.6M-20.22M-9.58M
Gain YTD32.0483.3921.003
P/E RatioN/AN/AN/A
Revenue503M1.03M1.92M
Total Cash295M26.3M7.71M
Total Debt795M31.2M0
FUNDAMENTALS RATINGS
BCRX vs PLUR vs PULM: Fundamental Ratings
BCRX
PLUR
PULM
OUTLOOK RATING
1..100
608052
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
71100100
SMR RATING
1..100
100100100
PRICE GROWTH RATING
1..100
427437
P/E GROWTH RATING
1..100
100100100
SEASONALITY SCORE
1..100
50n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (50) in the Biotechnology industry is in the same range as PLUR (50) and is in the same range as PULM (50). This means that BCRX's stock grew similarly to PLUR’s and similarly to PULM’s over the last 12 months.

BCRX's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as PLUR (100) and is in the same range as PULM (100). This means that BCRX's stock grew similarly to PLUR’s and similarly to PULM’s over the last 12 months.

BCRX's SMR Rating (100) in the Biotechnology industry is in the same range as PLUR (100) and is in the same range as PULM (100). This means that BCRX's stock grew similarly to PLUR’s and similarly to PULM’s over the last 12 months.

PULM's Price Growth Rating (37) in the Biotechnology industry is in the same range as BCRX (42) and is somewhat better than the same rating for PLUR (74). This means that PULM's stock grew similarly to BCRX’s and somewhat faster than PLUR’s over the last 12 months.

PULM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCRX (100) and is in the same range as PLUR (100). This means that PULM's stock grew similarly to BCRX’s and similarly to PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXPULM
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 22 days ago
70%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCT13.800.69
+5.26%
PureCycle Technologies
GPN78.982.63
+3.44%
Global Payments
BCO88.602.81
+3.28%
Brink's Company (The)
NREF13.84-0.05
-0.36%
NexPoint Real Estate Finance
LSF6.20-0.06
-0.96%
Laird Superfood

PLUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLUR has been loosely correlated with RZLT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PLUR jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
+0.68%
RZLT - PLUR
33%
Loosely correlated
+5.21%
KOD - PLUR
29%
Poorly correlated
-0.55%
RNA - PLUR
25%
Poorly correlated
+2.47%
CSBR - PLUR
25%
Poorly correlated
-3.47%
BEAM - PLUR
24%
Poorly correlated
+2.63%
More